Biomarin announces first quarter 2012 financial results Full Text
BioMarin Pharmaceutical Inc. announced financial results for the first quarter of 2012. GAAP net loss was $24.0 million ($0.21 per diluted share) for the first quarter of 2012, compared to GAAP net loss of $4.4 million ($0.04 per diluted share) for the first quarter of 2011. Non–GAAP adjusted EBITDA was a loss of $0.1 million for the first quarter of 2012, compared to non–GAAP adjusted EBITDA of $17.3 million for the first quarter of 2011. Non–GAAP adjusted EBITDA excludes depreciation and amortization, contingent consideration expense, interest income and expense, income taxes, stock compensation expense and material non–recurring items.